Opening book details…
About this Economics, Econometrics and Finance article
Cost-Effectiveness Analysis of Crohn’s Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist by Holko, Przemysław; Kawalec, Paweł; Pilc, Andrzej is a Economics, Econometrics and Finance article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Economics, Econometrics and Finance.
- Author
- Holko, Przemysław; Kawalec, Paweł; Pilc, Andrzej
- Publisher
- Springer International Publishing AG; Springer-Verlag; Adis International Ltd.; Springer Science and Business Media LLC (ISSN 1170-7690)
- Published
- 2018
- Language
- EN
- Field
- Economics, Econometrics and Finance (Social Sciences)
More by Holko, Przemysław; Kawalec, Paweł; Pilc, Andrzej
Browse all works by Holko, Przemysław; Kawalec, Paweł; Pilc, Andrzej